Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹28,801.1
₹61,200 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,525.7
₹31,555 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹864.1
₹7,832 Cr
Pharmaceuticals & Drugs
₹454.5
₹7,153 Cr
Pharmaceuticals & Drugs
₹491.2
₹4,483 Cr
Pharmaceuticals & Drugs
₹310.3
₹3,473 Cr
Pharmaceuticals & Drugs
₹99.7
₹2,561 Cr
Pharmaceuticals & Drugs
₹856.7
₹489 Cr
Pharmaceuticals & Drugs
₹97.5
₹276 Cr
Pharmaceuticals & Drugs
₹34.3
₹167 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,525.7
₹4,973 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹454.5
₹4,123 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹491.2
₹2,477 Cr
Pharmaceuticals & Drugs
₹864.1
₹1,946 Cr
Pharmaceuticals & Drugs
₹310.3
₹668 Cr
Pharmaceuticals & Drugs
₹99.7
₹221 Cr
Pharmaceuticals & Drugs
₹34.3
₹85 Cr
Pharmaceuticals & Drugs
₹28,801.1
₹6,714 Cr
Pharmaceuticals & Drugs
₹856.7
₹327 Cr
Pharmaceuticals & Drugs
₹97.5
₹449 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,525.7
₹974 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹454.5
₹347 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹864.1
₹268 Cr
Pharmaceuticals & Drugs
₹491.2
₹199 Cr
Pharmaceuticals & Drugs
₹99.7
₹145 Cr
Pharmaceuticals & Drugs
₹310.3
₹139 Cr
Pharmaceuticals & Drugs
₹34.3
₹4 Cr
Pharmaceuticals & Drugs
₹28,801.1
₹1,509 Cr
Pharmaceuticals & Drugs
₹856.7
₹6 Cr
Pharmaceuticals & Drugs
₹97.5
₹4 Cr

You may also like the below Video Courses